Form 8-K - Current report:
SEC Accession No. 0001683168-24-006456
Filing Date
2024-09-17
Accepted
2024-09-17 10:39:59
Documents
13
Period of Report
2024-09-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT canna_8k.htm   iXBRL 8-K 29460
  Complete submission text file 0001683168-24-006456.txt   204490

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cpmd-20240909.xsd EX-101.SCH 3030
3 XBRL LABEL FILE cpmd-20240909_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cpmd-20240909_pre.xml EX-101.PRE 22369
15 EXTRACTED XBRL INSTANCE DOCUMENT canna_8k_htm.xml XML 3798
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 241302910
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)